Rigel Pharmaceuticals | RIGL - Market Capitalization

Stock Price
29.51
Daily Change
-0.12 -0.41%
Monthly
-13.59%
Yearly
49.80%
Q1 Forecast
33.68

Rigel Pharmaceuticals reported $5.2B in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agenus USD 40M 24M Mar/2025
Amgen USD 176.25B 24.32B Dec/2025
Anika Therapeutics USD 213M 28M Mar/2025
Arrowhead Research USD 9.02B 4.25B Dec/2025
AstraZeneca USD 288.15B 55.08B Dec/2025
BioMarin Pharmaceutical USD 11.76B 348M Mar/2026
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Celldex Therapeutics USD 1.81B 87M Dec/2025
Daiichi Sankyo JPY 6.34T 62.51B Dec/2025
Eli Lilly USD 1.02T 293.84B Dec/2025
Halozyme Therapeutics USD 7.91B 664M Dec/2025
Ionis Pharmaceuticals USD 12.81B 2.39B Dec/2025
MacroGenics USD 106M 29M Sep/2025
Neurocrine Biosciences USD 14.14B 218M Dec/2025
Pfizer USD 141.57B 6.48B Dec/2025
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Ultragenyx Pharmaceutical USD 2.22B 680M Dec/2025
Veracyte USD 3.33B 627M Dec/2025